Loading...
•
Jun 30, 2023
Elevance Health Q2 2023 Earnings Report
Elevance Health reported strong financial performance in Q2 2023, marked by double-digit growth in revenue, operating earnings, and adjusted earnings per share, driven by solid execution and strategic progress.
Key Takeaways
Elevance Health reported a strong Q2 2023, with a 12.7% year-over-year increase in operating revenue to $43.4 billion and a 12.0% increase in operating gain to $2.6 billion. GAAP net income was $7.79 per share, and adjusted net income was $9.04 per share. Medical enrollment increased to 48.0 million members.
GAAP net income was $7.79 per share, including net negative adjustment items of $1.25 per share; adjusted net income was $9.04 per share.
Operating revenue grew 12.7% year-over-year to $43.4 billion.
Operating gain grew 12.0% year-over-year to $2.6 billion.
Medical enrollment increased by 938 thousand members year-over-year, reaching 48.0 million members.
Revenue by Segment
Forward Guidance
Elevance Health expects GAAP net income to be greater than $29.09 per share in 2023, and adjusted net income to be greater than $32.85 per share.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...